Treating ophthalmic fibrosis using interferon-alpha

Details Treating ophthalmic fibrosis using interferon-alpha Treating ophthalmic fibrosis using interferon-alpha

A - Human Necessities

61

K

A61K 38/21 (2006.01)

Patent

CA 2120950

2120950 9306856 PCTABS00021 The present invention relates to the use of topical interferon-.alpha. for the treatment of various forms of fibrosis in and around the eye arising from various ophthalmic diseases and procedures. Specifically the invention relates to alleviation of corneal scarring after laser photoablative refractive keratectomy (PRK). It aslo relates to the alleviation of posterior (lens) capsular opacification after extracapsular cataract surgery with lens implant; the alleviation of wound scarring following glaucoma filtration surgery. Interferon-.alpha. may also be used to coat the lens implant prior to or during implantation. It may also possibly be injected into the eye during eye surgery for inhibiting posterior capsule opacification after cataract surgery and in addition may be injected into the vitreous body to prevent retinal fibrosis and proliferative vitreo-retinopathy, and injected subconjunctivally to inhibit fibrosis and scarring following glaucoma filtration surgery.

Affiliated with

Also associated with

Rating

Treating ophthalmic fibrosis using interferon-alpha does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treating ophthalmic fibrosis using interferon-alpha, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating ophthalmic fibrosis using interferon-alpha will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1723641